company background image
XRAY

DENTSPLY SIRONANasdaqGS:XRAY Stock Report

Market Cap

US$10.6b

7D

-3.6%

1Y

-5.2%

Updated

02 Dec, 2021

Data

Company Financials +
XRAY fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance3/6
Financial Health4/6
Dividends4/6

XRAY Stock Overview

DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide.

DENTSPLY SIRONA Competitors

Cooper Companies

NYSE:COO

US$18.4b

Avanos Medical

NYSE:AVNS

US$1.4b

Danaher

NYSE:DHR

US$228.5b

Intuitive Surgical

NasdaqGS:ISRG

US$114.3b

Price History & Performance

Summary of all time highs, changes and price drops for DENTSPLY SIRONA
Historical stock prices
Current Share PriceUS$49.43
52 Week HighUS$69.54
52 Week LowUS$48.13
Beta0.88
1 Month Change-16.01%
3 Month Change-20.82%
1 Year Change-5.22%
3 Year Change35.54%
5 Year Change-15.94%
Change since IPO4,645.28%

Recent News & Updates

Nov 29
Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Nov 11
Is Now An Opportune Moment To Examine DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Is Now An Opportune Moment To Examine DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

DENTSPLY SIRONA Inc. ( NASDAQ:XRAY ) saw significant share price movement during recent months on the NASDAQGS, rising...

Shareholder Returns

XRAYUS Medical EquipmentUS Market
7D-3.6%-3.0%-3.5%
1Y-5.2%11.7%19.4%

Return vs Industry: XRAY underperformed the US Medical Equipment industry which returned 9.5% over the past year.

Return vs Market: XRAY underperformed the US Market which returned 17.8% over the past year.

Price Volatility

Is XRAY's price volatile compared to industry and market?
XRAY volatility
XRAY Average Weekly Movement3.5%
Medical Equipment Industry Average Movement7.5%
Market Average Movement6.1%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.4%

Stable Share Price: XRAY is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: XRAY's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
189915,000Don Caseyhttps://www.dentsplysirona.com

DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

DENTSPLY SIRONA Fundamentals Summary

How do DENTSPLY SIRONA's earnings and revenue compare to its market cap?
XRAY fundamental statistics
Market CapUS$10.56b
Earnings (TTM)US$418.00m
Revenue (TTM)US$4.25b

25.9x

P/E Ratio

2.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
XRAY income statement (TTM)
RevenueUS$4.25b
Cost of RevenueUS$1.90b
Gross ProfitUS$2.35b
ExpensesUS$1.93b
EarningsUS$418.00m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)1.91
Gross Margin55.29%
Net Profit Margin9.85%
Debt/Equity Ratio40.6%

How did XRAY perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

22%

Payout Ratio

Valuation

Is DENTSPLY SIRONA undervalued compared to its fair value and its price relative to the market?

43.2%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: XRAY ($49.43) is trading below our estimate of fair value ($86.99)

Significantly Below Fair Value: XRAY is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: XRAY is good value based on its PE Ratio (25.9x) compared to the US Medical Equipment industry average (45.4x).

PE vs Market: XRAY is poor value based on its PE Ratio (25.9x) compared to the US market (16.6x).


Price to Earnings Growth Ratio

PEG Ratio: XRAY is poor value based on its PEG Ratio (1.9x)


Price to Book Ratio

PB vs Industry: XRAY is good value based on its PB Ratio (2.1x) compared to the US Medical Equipment industry average (3.7x).


Future Growth

How is DENTSPLY SIRONA forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?

13.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: XRAY's forecast earnings growth (13.9% per year) is above the savings rate (2%).

Earnings vs Market: XRAY's earnings (13.9% per year) are forecast to grow slower than the US market (14.3% per year).

High Growth Earnings: XRAY's earnings are forecast to grow, but not significantly.

Revenue vs Market: XRAY's revenue (4.6% per year) is forecast to grow slower than the US market (10.1% per year).

High Growth Revenue: XRAY's revenue (4.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: XRAY's Return on Equity is forecast to be low in 3 years time (13%).


Past Performance

How has DENTSPLY SIRONA performed over the past 5 years?

26.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: XRAY has high quality earnings.

Growing Profit Margin: XRAY became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: XRAY has become profitable over the past 5 years, growing earnings by 26.8% per year.

Accelerating Growth: XRAY has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: XRAY has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (51.2%).


Return on Equity

High ROE: XRAY's Return on Equity (8.2%) is considered low.


Financial Health

How is DENTSPLY SIRONA's financial position?


Financial Position Analysis

Short Term Liabilities: XRAY's short term assets ($1.8B) exceed its short term liabilities ($1.1B).

Long Term Liabilities: XRAY's short term assets ($1.8B) do not cover its long term liabilities ($3.0B).


Debt to Equity History and Analysis

Debt Level: XRAY's net debt to equity ratio (35.1%) is considered satisfactory.

Reducing Debt: XRAY's debt to equity ratio has increased from 19% to 40.6% over the past 5 years.

Debt Coverage: XRAY's debt is well covered by operating cash flow (33.5%).

Interest Coverage: XRAY's interest payments on its debt are well covered by EBIT (11.2x coverage).


Balance Sheet


Dividend

What is DENTSPLY SIRONA current dividend yield, its reliability and sustainability?

0.89%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: XRAY's dividend (0.89%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.37%).

High Dividend: XRAY's dividend (0.89%) is low compared to the top 25% of dividend payers in the US market (3.69%).


Stability and Growth of Payments

Stable Dividend: XRAY's dividends per share have been stable in the past 10 years.

Growing Dividend: XRAY's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (22%), XRAY's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: XRAY's dividends in 3 years are forecast to be thoroughly covered by earnings (10.5% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.6yrs

Average management tenure


CEO

Don Casey (61 yo)

3.83yrs

Tenure

US$7,166,868

Compensation

Mr. Donald M. Casey, Jr., also known as Don, serves as CEO and Director at DENTSPLY International Inc., since 2018. Mr. Casey has been Chief Executive Officer and a Director at Dentsply Sirona Inc. since...


CEO Compensation Analysis

Compensation vs Market: Don's total compensation ($USD7.17M) is below average for companies of similar size in the US market ($USD11.11M).

Compensation vs Earnings: Don's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: XRAY's management team is considered experienced (2.6 years average tenure).


Board Members

Experienced Board: XRAY's board of directors are considered experienced (3.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: XRAY insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

DENTSPLY SIRONA Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: DENTSPLY SIRONA Inc.
  • Ticker: XRAY
  • Exchange: NasdaqGS
  • Founded: 1899
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: US$10.561b
  • Shares outstanding: 218.61m
  • Website: https://www.dentsplysirona.com

Number of Employees


Location

  • DENTSPLY SIRONA Inc.
  • 13320-B Ballantyne Corporate Place
  • Charlotte
  • North Carolina
  • 28277-3607
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/12/02 23:29
End of Day Share Price2021/12/02 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.